Alexandre S, Rast C, Nguyen-Ba G, Vasseur P
Université de Metz, Centre des Sciences de l'Environnement, Metz Cedex, F-57070, France.
Exp Cell Res. 2000 Feb 25;255(1):30-9. doi: 10.1006/excr.1999.4759.
The sensitivity of normal diploid Syrian hamster embryo (SHE) cells to apoptosis was tested after treatment with the topoisomerase inhibitors camptothecin and etoposide and after serum withdrawal. Programmed cell death (PCD) was identified through morphological, biochemical, and molecular changes and compared with that of HL60 cell line. The results showed that topoisomerase inhibitors, which were shown to be potent PCD inducers in the HL60 cell line, induced a weaker apoptotic response in SHE cells than after growth factor deprivation. In addition, serum-free medium, which rapidly induced apoptosis in SHE cells, did not affect the HL60 cell line. In both cell types, PCD was expressed by condensed chromatin, fragmented nuclei, and DNA laddering on electrophoretic gels, an indisputable sign of apoptosis. In apoptotic HL60 cells, the cleavage of 113-kDa poly(ADP-ribose)polymerase (PARP) resulted in the so-called apoptotic 89-kDa fragment and was associated with increased caspase-3 activity. In apoptotic SHE cells, PARP degraded early but the degradation profile was not characterized by the appearance of an 89-kDa fragment. Moreover, no activation of caspase-3 was noted. ZnCl(2), which is known to prevent protease activity responsible for apoptosis features, inhibited PARP cleavage and nuclear modifications induced by apoptotic stimuli in both cell types, but with a higher sensitivity in SHE cells. Apoptosis induced by serum deprivation was linked with c-myc negative regulation in SHE cells, but not with p53 protein accumulation, while topoisomerase inhibitors led to p53 stabilization without any change in c-myc expression. Serum-free medium and topoisomerase inhibitors did not modify c-myc expression in the HL60 cell line. The overall results demonstrated that apoptosis, which is a carefully regulated process of cell death, may proceed through mechanisms varying according to cell type or apoptosis inducer. In addition, markers which are generally considered hallmarks of apoptosis may fail to appear in some cell types.
在用拓扑异构酶抑制剂喜树碱和依托泊苷处理后以及血清撤除后,检测了正常二倍体叙利亚仓鼠胚胎(SHE)细胞对凋亡的敏感性。通过形态学、生化和分子变化鉴定程序性细胞死亡(PCD),并与HL60细胞系的程序性细胞死亡进行比较。结果表明,拓扑异构酶抑制剂在HL60细胞系中是有效的PCD诱导剂,但与生长因子剥夺后相比,其在SHE细胞中诱导的凋亡反应较弱。此外,能迅速诱导SHE细胞凋亡的无血清培养基对HL60细胞系没有影响。在这两种细胞类型中,PCD都表现为染色质浓缩、细胞核碎片化以及电泳凝胶上出现DNA梯带,这是凋亡的无可争议的标志。在凋亡的HL60细胞中,113 kDa聚(ADP - 核糖)聚合酶(PARP)的裂解产生了所谓的89 kDa凋亡片段,并与半胱天冬酶 - 3活性增加有关。在凋亡的SHE细胞中,PARP早期降解,但降解特征不是出现89 kDa片段。此外,未观察到半胱天冬酶 - 3的激活。已知能阻止负责凋亡特征的蛋白酶活性的ZnCl₂抑制了两种细胞类型中由凋亡刺激诱导的PARP裂解和细胞核修饰,但SHE细胞中的敏感性更高。血清剥夺诱导的凋亡与SHE细胞中的c - myc负调控有关,但与p53蛋白积累无关,而拓扑异构酶抑制剂导致p53稳定,c - myc表达无任何变化。无血清培养基和拓扑异构酶抑制剂未改变HL60细胞系中的c - myc表达。总体结果表明,凋亡是一个受到严格调控的细胞死亡过程,可能通过根据细胞类型或凋亡诱导剂而变化的机制进行。此外,通常被认为是凋亡标志的标志物在某些细胞类型中可能不会出现。